Exteris Stressgard is a next-generation fungicide containing a unique combination of two active ingredients, and two proprietary formulation technologies, delivering preventative and fast curative control of a broad spectrum of damaging turf diseases as well as improved plant health and turf quality. The unique formulation of Exteris Stressgard delivers a highly flexible product that turf managers can apply with confidence throughout the year and under a wide variety of environmental conditions.
“It’s a constant challenge to maintain peak playability throughout the season – especially when you’re fighting diseases, plant health and player perceptions,” said James Royal, Turf Market Manager for Bayer. “That understanding is the reason we continually work to harness the latest innovations in plant health and formulation technology to develop industry-leading solutions that offer the dependability and peace of mind our customers have come to expect from Bayer.”
Exteris Stressgard contains a new and exciting active ingredient for the turf market, fluopyram, utilising succinate dehydrogenase inhibition (SDHI) as its mode of action. Combined with the proven control of trifloxystrobin, Exteris Stressgard offers both systemic movement and translaminar activity, delivering broad-spectrum control of diseases like dollar spot, brown patch, fusarium and helminthosporium.
Exteris Stressgard is the first Bayer turf product in Australia to combine LEAF-COTE™ and Stressgard® FT. Australian superintendents who have trialled Exteris Stressgard reported thorough and uniform coverage of the leaf surface which is important to ensure rapid curative knockdown of damaging fungal mycelium and to maximise residual disease control. With Leaf-Cote Technology in Exteris Stressgard, turf managers will have a reliable fungicide that stays where it’s needed and has the versatility to work when unanticipated climatic changes occur.
“Bayer Stressgard FT products are patented and unique. With proven turf health benefits seen over 15 years of global research, superintendents can trust Bayer Stressgard FT fungicides to deliver outstanding disease control and healthy, high quality turf. To get the most out of Stressgard FT products, apply as part of a program, beginning prior to, and continuing through the key stress period. ExterisStressgard, together with SignatureTM Stressgard®, Interface® Stressgard and Reserve® Stressgard, expand the Bayer Stressgard FT portfolio in Australia? to four products”, James said.
“This choice gives more flexibility for superintendents to build disease control programs incorporating regular applications of Stressgard FT products which can be trusted to perform under the highest stress and disease pressure periods.
“We are thrilled to bring this exciting and revolutionary innovation to superintendents,” James said. “By focusing on the Bayer mission of ‘Science For a Better Life, we aim to provide solutions that incorporate science in new ways to provide the best possible tools for our customers to accomplish their jobs.”
Exteris Stressgard is sold in a 5L container and has a labelled application rate of 10L per hectare. Recommended spray volume is 400L-800L water per hectare.
* Available from Bayer's Turf Agency Network from July 2, 2018.
(m) 0408 903 252
About Bayer in Australia
Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. It has operated in Australia since 1925 and has a long term commitment to the health of Australians. Locally, Bayer currently employs almost 900 people across the country and is dedicated to servicing the needs of rural Australia and the local community. Bayer is deeply committed to research and development and has a strong tradition of innovation. The company’s focus on people, partnerships and innovation underpins all aspects of its operations, consistent with its mission, “Bayer: Science For A Better Life.” crop.bayer.com.au
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.